TY - JOUR
T1 - Clinical practice guidelines for the management of biliary tract cancers 2019
T2 - The 3rd English edition
AU - Nagino, Masato
AU - Hirano, Satoshi
AU - Yoshitomi, Hideyuki
AU - Aoki, Taku
AU - Uesaka, Katsuhiko
AU - Unno, Michiaki
AU - Ebata, Tomoki
AU - Konishi, Masaru
AU - Sano, Keiji
AU - Shimada, Kazuaki
AU - Shimizu, Hiroaki
AU - Higuchi, Ryota
AU - Wakai, Toshifumi
AU - Isayama, Hiroyuki
AU - Okusaka, Takuji
AU - Tsuyuguchi, Toshio
AU - Hirooka, Yoshiki
AU - Furuse, Junji
AU - Maguchi, Hiroyuki
AU - Suzuki, Kojiro
AU - Yamazaki, Hideya
AU - Kijima, Hiroshi
AU - Yanagisawa, Akio
AU - Yoshida, Masahiro
AU - Yokoyama, Yukihiro
AU - Mizuno, Takashi
AU - Endo, Itaru
N1 - Funding Information:
This guideline was reviewed by the following two appraisal committee members: Masaru Miyazaki, International University of Health and Welfare, Ichikawa, Japan; and Tadahiro Takada, Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan. The preparation of this guideline was supported by the JSHPBS.
Funding Information:
This guideline was reviewed by the following two appraisal committee members: Masaru Miyazaki, International University of Health and Welfare, Ichikawa, Japan; and Tadahiro Takada, Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan. The preparation of this guideline was supported by the JSHPBS.
Publisher Copyright:
© 2020 Japanese Society of Hepato-Biliary-Pancreatic Surgery
PY - 2021/1
Y1 - 2021/1
N2 - Background: The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract cancers (cholangiocarcinoma, gallbladder cancer, and ampullary cancer) in 2007, then published the 2nd version in 2014. Methods: In this 3rd version, clinical questions (CQs) were proposed on six topics. The recommendation, grade for recommendation, and statement for each CQ were discussed and finalized by an evidence-based approach. Recommendations were graded as Grade 1 (strong) or Grade 2 (weak) according to the concepts of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Results: The 31 CQs covered the six topics: (a) prophylactic treatment, (b) diagnosis, (c) biliary drainage, (d) surgical treatment, (e) chemotherapy, and (f) radiation therapy. In the 31 CQs, 14 recommendations were rated strong and 14 recommendations weak. The remaining three CQs had no recommendation. Each CQ includes a statement of how the recommendations were graded. Conclusions: This latest guideline provides recommendations for important clinical aspects based on evidence. Future collaboration with the cancer registry will be key for assessing the guidelines and establishing new evidence.
AB - Background: The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract cancers (cholangiocarcinoma, gallbladder cancer, and ampullary cancer) in 2007, then published the 2nd version in 2014. Methods: In this 3rd version, clinical questions (CQs) were proposed on six topics. The recommendation, grade for recommendation, and statement for each CQ were discussed and finalized by an evidence-based approach. Recommendations were graded as Grade 1 (strong) or Grade 2 (weak) according to the concepts of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Results: The 31 CQs covered the six topics: (a) prophylactic treatment, (b) diagnosis, (c) biliary drainage, (d) surgical treatment, (e) chemotherapy, and (f) radiation therapy. In the 31 CQs, 14 recommendations were rated strong and 14 recommendations weak. The remaining three CQs had no recommendation. Each CQ includes a statement of how the recommendations were graded. Conclusions: This latest guideline provides recommendations for important clinical aspects based on evidence. Future collaboration with the cancer registry will be key for assessing the guidelines and establishing new evidence.
KW - biliary tract cancer
KW - clinical practice
KW - guideline
UR - http://www.scopus.com/inward/record.url?scp=85098000027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098000027&partnerID=8YFLogxK
U2 - 10.1002/jhbp.870
DO - 10.1002/jhbp.870
M3 - Article
C2 - 33259690
AN - SCOPUS:85098000027
SN - 1868-6974
VL - 28
SP - 26
EP - 54
JO - Journal of Hepato-Biliary-Pancreatic Sciences
JF - Journal of Hepato-Biliary-Pancreatic Sciences
IS - 1
ER -
